When properly labd, each vial can support multiple withdrawals over an extended period
Anyone with autoimmune disease, cancer history, or on multiple medications should consult a doctor before experimenting because BPC157 is, in all practical terms, an unapproved drug with unknown interactions
Safety depends on (1) the peptide, (2) the route, (3) quality controls, (4) your personal risk factors, and (5) whether the combination has evidence
PMC 4557054
The unique peptide composition of Novera KLOW includes BPC 157 10mg, GHK-Cu 50mg, TB500 10mg, and KPV 10mg
Comprehensive biochemical testing demonstrates that 5 amino 1mq does not inhibit structurally similar methyltransferases, including catechol-O-methyltransferase (COMT), DNA methyltransferase 1 (DNMT1), or protein arginine methyltransferase 3 (PRMT3)